Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hanna Karla Andrade Guapyassú Machado"'
Autor:
Murilo Catafesta das Neves, Augusto Riedel Abrahão, Marcio Abrahão, Marcello Rosano, Lillian Andrade da Rocha, Hanna Karla Andrade Guapyassu Machado, Rodrigo Oliveira Santos
Publikováno v:
Brazilian Journal of Otorhinolaryngology, Vol 88, Iss 5, Pp 740-744 (2022)
Introduction: Surgical treatment of hyperparathyroidism related to chronic kidney disease is a real challenge for Brazilian public health care. High cost medications and long waiting lines to perform preoperative exams, especially technetium Tc 99m S
Externí odkaz:
https://doaj.org/article/68a6864e34884be4b1ea7b61aea3f1de
Autor:
Hanna Karla Andrade Guapyassú Machado, Carolina Steller Wagner Martins, Vanda Jorgetti, Rosilene Motta Elias, Rosa Maria Affonso Moysés
Publikováno v:
Brazilian Journal of Nephrology
Abstract Background: Current guidelines recommend assessment of 25-vitamin D status in patients with chronic kidney disease (CKD). Although significant differences among assays have been described, the impact of CKD on this variability has never been
Externí odkaz:
https://doaj.org/article/22ac741462e6409aaacc5c531810c618
Autor:
Vanda Jorgetti, Carolina Steller Wagner Martins, Hanna Karla Andrade Guapyassú Machado, Rosilene M. Elias, Rosa M.A. Moysés
Publikováno v:
Jornal Brasileiro de Nefrologia
Brazilian Journal of Nephrology
Brazilian Journal of Nephrology
Background: Current guidelines recommend assessment of 25-vitamin D status in patients with chronic kidney disease (CKD). Although significant differences among assays have been described, the impact of CKD on this variability has never been tested.
Autor:
Hilton Leão-Filho, Hanna Karla Andrade Guapyassú Machado, Rosse Osório, Luciene M. dos Reis, Rosilene Motta, Carlos E. Rochitte, Rosa M.A. Moysés, Melani Ribeiro Custódio, Lucas Acatauassu Nunes, Vanda Jorgetti
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background Chronic kidney disease (CKD) is associated with several comorbidities, including anemia, since with decreased renal function there is a decrease in erythropoietin (EPO) production and changes in iron (Fe) metabolism. In hemodialysis patien